Numerous studies based on cellular and mouse models have shown that QUE has therapeutic effects on metabolic disorders through a variety of mechanisms, such as increasing adiponectin, decreasing leptin, and antioxidant activity (Mariani et al., 2008). The gene discussed is LEP; the disease is Other metabolic disease.